Legal & General Group Plc Takes Position in Danaher Corporation $DHR

Legal & General Group Plc purchased a new position in Danaher Corporation (NYSE:DHRFree Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 811,568 shares of the conglomerate’s stock, valued at approximately $584,361,000. Legal & General Group Plc owned 0.12% of Danaher as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of the business. High Note Wealth LLC lifted its holdings in Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares during the period. First Command Advisory Services Inc. increased its holdings in shares of Danaher by 4.4% in the 4th quarter. First Command Advisory Services Inc. now owns 1,104 shares of the conglomerate’s stock valued at $253,000 after acquiring an additional 47 shares during the period. GW&K Investment Management LLC increased its holdings in shares of Danaher by 8.4% in the 4th quarter. GW&K Investment Management LLC now owns 605 shares of the conglomerate’s stock valued at $138,000 after acquiring an additional 47 shares during the period. Kestra Private Wealth Services LLC raised its position in shares of Danaher by 0.3% in the 3rd quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock worth $3,057,000 after acquiring an additional 48 shares in the last quarter. Finally, SOL Capital Management CO lifted its stake in shares of Danaher by 2.7% during the 4th quarter. SOL Capital Management CO now owns 1,879 shares of the conglomerate’s stock worth $430,000 after purchasing an additional 50 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of Danaher stock opened at $215.18 on Tuesday. The firm has a market capitalization of $151.27 billion, a P/E ratio of 38.22, a PEG ratio of 2.72 and a beta of 0.78. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a 50 day moving average price of $196.49 and a 200 day moving average price of $192.39.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the prior year, the business posted $0.77 EPS. Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. Sell-side analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. Evercore reiterated an “outperform” rating and issued a $230.00 target price on shares of Danaher in a research note on Monday, July 6th. DZ Bank assumed coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target on the stock. Wells Fargo & Company cut their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. Stifel Nicolaus decreased their target price on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Check Out Our Latest Research Report on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.